Biopharma Rallies Behind FDA After Texas Abortion Pill Ruling

In an open letter published Monday, more than 480 biopharma industry leaders, including Pfizer CEO Albert Bourla and former Alnylam founding CEO John Maraganore, expressed their support for the FDA after a Texas federal judge ruled to hold the approval of the abortion pill mifepristone.